Compare DAKT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAKT | VIR |
|---|---|---|
| Founded | 1968 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.1M | 843.1M |
| IPO Year | 1994 | 2019 |
| Metric | DAKT | VIR |
|---|---|---|
| Price | $21.58 | $7.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $26.00 | ★ $28.63 |
| AVG Volume (30 Days) | 423.5K | ★ 1.8M |
| Earning Date | 03-04-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $770,283,000.00 | $16,860,000.00 |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $7.35 | N/A |
| P/E Ratio | $147.22 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.24 | $4.16 |
| 52 Week High | $24.38 | $11.39 |
| Indicator | DAKT | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 66.63 |
| Support Level | $21.01 | $5.80 |
| Resistance Level | $22.67 | $7.75 |
| Average True Range (ATR) | 0.67 | 0.47 |
| MACD | 0.03 | 0.17 |
| Stochastic Oscillator | 66.35 | 88.83 |
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.